Promising Alzheimer’s drug needs to be studied for safety, researchers say
Comment this story Comment An experimental drug for Alzheimer’s disease moderately slowed the effects of the disease, but was linked to patient safety risks that warrant longer clinical trials, according to a study published Tuesday evening. The study, published in the New England Journal of Medicine, found that a drug developed by Tokyo-based Eisai and …
Promising Alzheimer’s drug needs to be studied for safety, researchers say Read More »